Skip to main content
. 2019 Oct 11;12:1756284819881301. doi: 10.1177/1756284819881301

Table 2.

Univariate and multivariate analyses of predictive factors associated with clinical response to EEN in the cCD.

Univariate analysis
Multivariate analysis
Remission (n = 45) Nonremission (n = 40) p Odds ratio (95% CI) p
Male 27 21 0.487
Age 34.49 ± 12.65 31.45 ± 13.82 0.291
Duration (months) 51.02 ± 45.12 50.73 ± 44.43 0.975
Smoke 6 2 0.207
Surgery 21 13 0.201
Maintenance therapy
 None 24 22 1
 Mesalazine 7 5 0.704
 Azathioprine 7 8 0.711
 Thalidomide 2 2 0.933
 Sulfasalazine 4 1 0.261
 Tripterygium 1 2 0.536
BMI 18.6 ± 2.72 17.33 ± 2.9 0.032 0.905 (0.674–1.214) 0.506
B
 1 10 12 1
 2 17 13 0.425
 3 18 15 0.509
P 16 14 0.957
Pancolitis 6 13 <0.001 4.896 (1.223–19.607) 0.025
Feature of lesion 2.320 (1.143–4.708) 0.020
 Aphtha ulcers 29 8 1
 Fissuring ulcers 7 13 0.526
 Stricturing 7 20 <0.001
 Stricturing and ulcers 2 9 0.001
SES-CD 4.56 ± 3.25 8.80 ± 4.28 <0.001 1.892 (1.086–4.117) 0.014
CRP (mg/l) 43.0 ± 37.75 58.85 ± 54.9 0.130 1.014 (1.011–1.030) 0.041
ESR (mm/h) 41.18 ± 25.80 36.38 ± 26.59 0.403
Alb (g/l) 36.89 ± 5.91 35.45 ± 6.74 0.311
Pre-Alb (g/l) 136.04 ± 70.86 128.4 ± 71.15 0.620
∆Pre-Alb (g/l) 37.58 ± 73.56 −4.40 ± 59.68 0.008 0.983 (0.972–0.995) 0.005
LBMI (kg/m2) 8.38 ± 1.22 7.7 ± 1.47 0.014 0.377 (0.206–0.689) 0.002

Data shown as mean ± SD and n (%).

Alb, albumin; BMI, body mass index; B1, non-stricturing non-penetrating; B2, structuring; B3, penetrating; cCD, isolated colonic Crohn’s disease; CI, confidence interval; CRP, C-reactive protein; EEN, exclusive enteral nutrition; ESR, erythrocyte sedimentation rate; HBI, Harvey-Bradshaw Index; LBMI, lean body mass index; P, perianal lesions; Pre-Alb, prealbumin; SES-CD, simple endoscopic score for Crohn’s disease; SD, standard deviation.